ChromaVision Stock Surges on Sales News
- Share via
Dow Jones
ChromaVision Medical System Inc.’s stock rose nearly 17% Thursday after the company said two national health agencies agreed to purchase its automated cellular imaging system for cancer research.
Shares of the San Juan Capistrano maker of imaging systems rose $1.97 to $13.63 in Nasdaq trading.
The agencies--the National Institutes of Health and the National Cancer Institute’s basic sciences division--agreed to purchase the imaging system for an undisclosed amount, ChromaVision said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
